For decades, the standard for diagnosing complex conditions—particularly cancer—has been the tissue biopsy. While effective, the process is…
Read More →Circulating Tumor Cells (CTCs) are rare, elusive, and incredibly valuable for clinical diagnostics and cancer research. While traditional en…
Read More →In the rapidly evolving landscape of diagnostics, BloodScan Biotech is setting new benchmarks. By leveraging cutting-edge biomarker analysis…
Read More →Circulating Tumor Cells (CTCs) are rare cells that shed from primary tumors into the bloodstream, serving as vital biomarkers for cancer met…
Read More →The Shift Toward Precision Oncology For decades, the traditional tissue biopsy has been the gold standard for diagnosing and staging solid t…
Read More →In the era of precision oncology, selecting the right biomarker testing modality is critical for patient outcomes. As we move toward persona…
Read More →In the rapidly evolving field of precision oncology, the ability to detect and analyze cancer at the molecular level is paramount. Tradition…
Read More →For decades, the standard path to a cancer diagnosis has often involved invasive biopsies, imaging scans, and waiting periods that can feel…
Read More →Understanding Liquid Biopsy: A New Frontier in Diagnostics For decades, the standard way to diagnose cancer or monitor its progression has b…
Read More →In the ongoing battle against cancer, the ability to detect and analyze tumors early is paramount. Among the most promising frontiers in pre…
Read More →In oncology clinical trials, CTC enumeration and ctDNA analysis are two complementary liquid biopsy approaches for monitoring how a patient'…
Read More →Some blood tests can pick up signs of cancer early by detecting circulating tumor cells (CTCs) — whole cancer cells shed from a tumor into t…
Read More →A CTC liquid biopsy's accuracy comes down to two questions: how reliably it captures circulating tumor cells from blood, and how faithfully…
Read More →Circulating tumor cells (CTCs) are whole, intact cancer cells that break away from a primary or metastatic tumor and travel through the bloo…
Read More →CTCs and ctDNA are the two most common liquid biopsy analytes, but they are fundamentally different. ctDNA is fragmented tumor DNA released…
Read More →In oncology clinical trials, repeatedly biopsying tissue is often impractical or unsafe. Circulating tumor cells (CTCs) provide a non-invasi…
Read More →Tissue biopsy is the long-standing diagnostic gold standard, but it samples a single tumor site at a single point in time and is not always…
Read More →